Nurix Therapeutics Inc (NRIX)

Operating Cash Flow (Statement)

$379.31M

TTM · Period ending: · USD

NRIX logo

NRIX Operating Cash Flow (Statement)

Latest reported$379.31M
NRIX TTM Cash from Operations ($601.00K → $379.31M)
High-resolution chart · PNG

NRIX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nurix Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
379,312,000
-293,704,000
-260,292,000
-249,465,000
-230,384,000
-215,176,000
-191,720,000
-172,584,000
-97,144,000
-96,100,000
-74,864,000
-81,365,000
-146,009,000
-151,184,000
-165,629,000
-159,807,000
-152,763,000
-136,427,000
-135,048,000
-84,365,000
-73,936,000
-50,105,000
-32,999,000
-80,000
7,654,000
50,167,000
51,255,000
601,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.